Cargando…

Proton pump inhibitors increase the severity of hepatic encephalopathy in cirrhotic patients

BACKGROUND: Liver cirrhosis is the late stage of hepatic fibrosis and is characterized by portal hypertension that can clinically lead to decompensation in the form of ascites, esophageal/gastric varices or encephalopathy. The most common sequelae associated with liver cirrhosis are neurologic and n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fasullo, Matthew, Rau, Prashanth, Liu, Dong-Qi, Holzwanger, Erik, Mathew, Jomol P, Guilarte-Walker, Yurima, Szabo, Gyongyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Basic Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603505/ https://www.ncbi.nlm.nih.gov/pubmed/31293720 http://dx.doi.org/10.4254/wjh.v11.i6.522

Ejemplares similares

Video capsule endoscopy as a tool for evaluation of obscure overt gastrointestinal bleeding in the intensive care unit
por: Hakimian, Shahrad, et al.
Publicado: (2018)

Effect of proton pump inhibitors on mortality of cirrhotic patients with pneumonia
por: Hung, Tsung-Hsing, et al.
Publicado: (2019)

Association between proton pump inhibitors and hepatic encephalopathy: A meta-analysis
por: Bian, Jin, et al.
Publicado: (2017)

Proton pump inhibitor induced collagen expression in colonocytes is associated with collagenous colitis
por: Mori, Shiori, et al.
Publicado: (2017)

Short-Term Proton Pump Inhibitor Use and Hepatic Encephalopathy Risk in Patients with Decompensated Cirrhosis
por: Kuan, Yi-Chun, et al.
Publicado: (2019)

Psychometric Hepatic Encephalopathy Score for the Diagnosis of Minimal Hepatic Encephalopathy in Thai Cirrhotic Patients
por: Thanapirom, Kessarin, et al.
Publicado: (2023)

Association of proton pump inhibitors with risk of hepatic encephalopathy in advanced liver disease: A meta-analysis
por: Tantai, Xin-Xing, et al.
Publicado: (2019)

Proton pump inhibitor use increases hepatic encephalopathy risk: A systematic review and meta-analysis
por: Ma, Yun-Jie, et al.
Publicado: (2019)

Electroencephalography Signatures for Hepatic Encephalopathy in Cirrhosis Patients Treated with Proton Pump Inhibitors: An Exploratory Pilot Study
por: Zhang, Pan, et al.
Publicado: (2022)

Association of Proton Pump Inhibitor Therapy with Hepatic Encephalopathy in Hepatitis B Virus-related Acute-on-Chronic Liver Failure
por: Lin, Zhao-Ni, et al.
Publicado: (2014)

Cerebral Hemodynamics and Cognitive Function in Cirrhotic Patients with Hepatic Encephalopathy
por: Zhou, Yuqing, et al.
Publicado: (2016)

Reduced Cortical Complexity in Cirrhotic Patients with Minimal Hepatic Encephalopathy
por: Chen, Qiu-Feng, et al.
Publicado: (2020)

Prediction and Risk Factors for Prognosis of Cirrhotic Patients with Hepatic Encephalopathy
por: Peng, Ying, et al.
Publicado: (2021)

Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy
por: Tamai, Yasuyuki, et al.
Publicado: (2021)

Nutritional Deficiencies and Clinical Practices in Decompensated Cirrhotics With Hepatic Encephalopathy
por: Panchani, Nishah N, et al.
Publicado: (2022)

Proton Pump Inhibitors Intake and Iron and Vitamin B12 Status: A Prospective Comparative Study with a Follow up of 12 Months
por: Qorraj-Bytyqi, Hasime, et al.
Publicado: (2018)

Duration of the acute hepatic encephalopathy episode determines survival in cirrhotic patients
por: Ventura-Cots, Meritxell, et al.
Publicado: (2017)

Low yield of head CT in cirrhotic patients presenting with hepatic encephalopathy
por: Hanna, Angy, et al.
Publicado: (2021)

The prognosis and incidence of hepatic encephalopathy of patients with liver cirrhosis treated with proton pump inhibitors: A multicenter retrospective study in Japan
por: Sakamaki, Akira, et al.
Publicado: (2021)

Meta-analysis associates proton pump inhibitor use with higher pneumonia risk in cirrhotic patients: mining for “diamonds” in the coal
por: Tziatzios, Georgios, et al.
Publicado: (2020)

Determining the Risk of Spontaneous Bacterial Peritonitis due to increase use of Proton Pump Inhibitors among cirrhotic patients with ascites
por: Shaikh, Bashir Ahmed, et al.
Publicado: (2021)

Proton Pump Inhibitors Use and Increased Risk of Spontaneous Bacterial Peritonitis in Cirrhotic Patients: A Retrospective Cohort Analysis
por: Dahabra, Loai, et al.
Publicado: (2022)

Potassium-competitive acid blockers - are they the next generation of proton pump inhibitors?
por: Rawla, Prashanth, et al.
Publicado: (2018)

Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction
por: Wang, Wei-Wei, et al.
Publicado: (2017)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Clinical and Pathophysiological Characteristics of Cirrhotic Patients with Grade 1 and Minimal Hepatic Encephalopathy
por: Thomsen, Karen Louise, et al.
Publicado: (2016)

Reversibility of minimal hepatic encephalopathy following liver transplantation in Egyptian cirrhotic patients
por: Osman, Mahmoud A, et al.
Publicado: (2016)

Natural history of covert hepatic encephalopathy: An observational study of 366 cirrhotic patients
por: Wang, An-Jiang, et al.
Publicado: (2017)

Use of proton pump inhibitors is associated with a higher risk of pneumonia in cirrhotic patients: a systematic review and meta-analysis
por: Wongtrakul, Wasit, et al.
Publicado: (2020)

Proton pump inhibitors use and risk of developing spontaneous bacterial peritonitis in cirrhotic patients: A systematic review and meta-analysis
por: Alhumaid, Saad, et al.
Publicado: (2021)

Pump-Opathies: Mutations in Na(+)–K(+)-ATPase Genes Produce Severe Developmental Epileptic Encephalopathies
por: Stafstrom, Carl E.
Publicado: (2021)

Primary Prophylaxis to Prevent the Development of Hepatic Encephalopathy in Cirrhotic Patients with Acute Variceal Bleeding
por: Higuera-de-la-Tijera, Fátima, et al.
Publicado: (2018)

Radiomics‐based classification models for HBV‐related cirrhotic patients with covert hepatic encephalopathy
por: Luo, Sha, et al.
Publicado: (2020)

The role of functional magnetic resonance imaging of the brain in the evaluation of hepatic encephalopathy in cirrhotic patients
por: Abdelhamid, Muhammad Ahmed Magdy, et al.
Publicado: (2022)

EncephalApp Stroop Test for covert hepatic encephalopathy screening in Tunisian cirrhotic patients
por: Hamzaoui, Lamine, et al.
Publicado: (2023)

Wall shear stress in portal vein of cirrhotic patients with portal hypertension
por: Wei, Wei, et al.
Publicado: (2017)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

A Patient on Long-Term Proton Pump Inhibitors Develops Sudden Seizures and Encephalopathy: An Unusual Presentation of Hypomagnesaemia
por: Gandhi, Nirav Y., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1c70id7gkss6s8osgff1inkjic